Noxalk Ceritinib in Natco, India, is only 5% of the price in the United States.

in #ceritinib6 years ago

Noxalk.jpg
Ceritinib (trade name Zykadia ) is a prescription-only drug used for the treatment non-small cell lung cancer (NSCLC). It was developed by Novartis and received FDA approval for use in April 2014.

Zykadia Ceritinib 150 mg 150 Capsules sells for roughly $17,200 in the United States.

Ceritinib(Spexib ) sells in India at roughly 25% of the price in the United States.

Natco Pharma Ltd, India's largest pharmaceutical company, launched Noxalk Ceritinib 150mg, a generic drug of Zykadia.

Noxalk Ceritinib 150mg sells for 90 Capsules at only 5% of Zykadia in the United States.

This gives patients more and cheaper choices.

450 mg Ceritinib orally once daily with food,Each box of 90 capsules can be taken for one month.